drugset / Trial / NCT01099176

Effects of Hypolipemic Treatment on Adipokines

NCT01099176

RandomizedParallel-groupDouble-blindBasic science

Summary

The study is planned to show whether monotherapies or combined hypolipemic therapy influence the fasting plasma glucose, serum adipokines (leptin, adiponectin, resistin) and proinflammatory cytokines (interleukin-6, TNF alpha) during 30 and 90 day course.

Timeline

Start
2008-05
Primary completion
2009-05
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg Oral
Subject Fenofibrate Small molecule 267 mg Oral